Navigation Links
As colorectal cancer gets more aggressive, treatment with grape seed extract is even more effective
Date:1/17/2013

When the going gets tough, grape seed extract gets going: A University of Colorado Cancer Center study recently published in the journal Cancer Letters shows that the more advanced are colorectal cancer cells, the more GSE inhibits their growth and survival. On the other end of the disease spectrum, GSE leaves healthy cells alone entirely.

"We've known for quite a while that the bioactive compounds in grape seed extract selectively target many types of cancer cells. This study shows that many of the same mutations that allow colorectal cancer cells to metastasize and survive traditional therapies make them especially sensitive to treatment with GSE," says Molly Derry, doctoral candidate in the lab of Rajesh Agarwal, PhD, investigator at the CU Cancer Center and professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences.

Derry notes this is an especially important finding in light of increasing colorectal cancer rates (due in part to increasingly high-fat diets and sedentary lifestyles) and a low screening rate; that means 60 percent of patients diagnosed have already reached the advanced stage of the disease.

"Finding a way to selectively target advanced colorectal cancer cells could have major clinical importance," Derry says.

The group performed their experiments on colorectal cancer cell lines representing various stages of the disease. Whereas it generally takes much more chemotherapy to kill a stage IV cancer cell than a stage II cancer cell, Derry saw that the reverse was true with grape seed extract.

"It required less than half the concentration of GSE to suppress cell growth and kill 50 percent of stage IV cells than it did to achieve similar results in the stage II cells," Derry says.

The group also discovered a likely mechanism of GSE's preferential targeting of advanced colorectal cancer cells: when cancer cells were treated with antioxidants the GSE induced cell death was reversed and so Derry and colleagues consider it likely that GSE targets colorectal cancer through inducing oxidative stress that leads to the programmed cell death known as apoptosis.

"A colorectal cancer cell can have upwards of 11,000 genetic mutations differences from the DNA in healthy cells. Traditional chemotherapies may only target a specific mutation and as cancer progresses more mutations occur. These changes can result in cancer that is resistance to chemotherapy. In contrast, the many bioactive compounds of GSE are able to target multiple mutations. The more mutations a cancer presents, the more effective GSE is in targeting them," Derry says.

The Agarwal Lab continues its preclinical work studying the effectiveness and action of dietary compounds against cancer and encourages further exploration of their findings in clinical settings.


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. New model may help predict response to chemotherapy for colorectal cancer
2. Surgical-site infections may increase risk of deadly blood clots after colorectal surgery
3. Inclusion of CTC as HEDIS screening modality could increase colorectal cancer screening compliance
4. Multiple sclerosis drug may one day treat colorectal cancer
5. Patients with family history of colorectal cancer may be at risk for aggressive form of the disease
6. Breath test could possibly diagnose colorectal cancer
7. New electrically-conductive polymer nanoparticles can generate heat to kill colorectal cancer cells
8. Gene mutation identifies colorectal cancer patients who live longer with aspirin therapy
9. A recipe for increased colorectal cancer screening rates
10. Surgical patient safety program lowers SSIs by one-third following colorectal operations
11. Colonoscopy screening markedly reduces colorectal cancer incidence and death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER ... ions found in power plant water and steam. , Chlorides and sulfates cause ... boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Executives, Staff & Clients of ... for the Toys for Tots Literacy Campaign at their Semi-Annual Graduation and Fundraiser Event ... billion, the U.S. ranks at number 14 internationally in literacy. Statistically, a direct relation ...
(Date:3/28/2017)... ... March 28, 2017 , ... A ... achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing ... should be aware of when utilizing dental laboratories and technicians that create these ...
(Date:3/28/2017)... Santa Monica, CA (PRWEB) , ... March 28, ... ... expert, Dr. Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer ... newest gastric balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice ... Atlantic City March 13-16, was a busy spot this year. Liz Solovay and ... strategies for preventing outbreaks among camp communities during the upcoming 2017 camping season. ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017 The ... digital health and data analytics company, signed a ... for improving healthcare delivery in the region. ... for Global Health Research and Technology (BIGHEART) at ... on several topics related to healthcare IT and ...
(Date:3/27/2017)... Summary This report provides ... and its partnering interests and activities since 2010. Description ... in-depth insight into the partnering activity of one of the ... reports are prepared upon purchase to ensure inclusion of the ... The report will be delivered in PDF format within 1 ...
(Date:3/27/2017)... 27, 2017  A recent study at Shriners Hospitals ... hospitals in the country dedicated to the treatment of ... concluded that the Surfacide Helios ® UV-C Disinfection ... reducing bacterial pathogens not killed by the EVS (manual) ... the American Burn Association,s 49th Annual Meeting in ...
Breaking Medicine Technology: